Streetbeat News

Earnings

VRNS

Varonis has raised its FY24 revenue guidance from $536M-$546M to $544M-$552M, surpassing the estimated $542.242M. Additionally, the company has increased its adjusted EPS guidance from $0.13-$0.16 to $0.22-$0.24, exceeding the estimated $0.17.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:24 pm

CNO

CNO Financial Group has raised its full-year guidance on earnings and cash flow, indicating strong financial performance and positive future outlook.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:24 pm

LSCC

Lattice Semiconductor Corporation (NASDAQ:LSCC) shares fell after reporting worse-than-expected Q2 results. The company missed both earnings and sales estimates, with earnings per share at 23 cents and sales at $124.076 million. This represents significant declines from the same period last year. The company cited cyclic industry headwinds but remains optimistic about long-term growth.

Portfolio Pulse from Erica Kollmann

July 29, 2024 | 8:23 pm

LSCC

Lattice Semiconductor has provided a Q3 revenue forecast of $117M-$137M, which is below the estimated $142.47M.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:23 pm

CENT

Central Garden & Pet Company (CENT) is scheduled to report its earnings on August 7, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:23 pm

TTOO

T2 Biosystems (NASDAQ:TTOO) reported a Q2 2024 GAAP EPS of $(0.66), beating the analyst estimate of $(0.97) by 31.96%. However, the company missed its sales estimate, reporting $1.952 million against the expected $2.100 million, a 7.05% shortfall and a 0.61% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:22 pm

CDP

COPT Defense Properties (CDP) has updated its FY 2024 diluted EPS guidance to a range of $2.51-$2.57, significantly higher than the previous range of $1.19-$1.25.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:22 pm

CNO

CNO Financial Group (NYSE:CNO) reported strong Q2 earnings, with adjusted EPS of $1.05 beating the $0.71 estimate and sales of $1.07 billion surpassing the $943.98 million estimate. This represents a significant year-over-year increase in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:22 pm

PCH

PotlatchDeltic (NASDAQ:PCH) reported Q2 2024 adjusted EPS of $0.17, beating the estimate of $0.16. Sales were $320.671M, surpassing the $304.760M estimate. EPS increased by 183.33% YoY, and sales grew by 30.30% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:22 pm

EKSO

Ekso Bionics Holdings (NASDAQ:EKSO) reported Q2 2024 GAAP EPS of $(0.13), beating the estimate of $(0.14). However, sales of $4.950M missed the $5.171M estimate, though they increased by 5.25% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 8:21 pm